Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)

Robert Joseph Fitzgibbons, Henry T. Lynch, G. V. Stanislav, P. A. Watson, Stephen J. Lanspa, J. N. Marcus, T. Smyrk, M. D. Kriegler, J. F. Lynch

Research output: Contribution to journalArticle

158 Citations (Scopus)

Abstract

Primary genetic factors are etiologic in at least 5-10% of patients with colon cancer. The polyposis syndromes (FPC) are easily identified examples because of the spectacular number of polyps. The hereditary nonpolyposis syndromes (HNPCC), although five times more common than FPC, are usually not recognized because they do not have such a distinctive clinical, premonitory genetic marker. Colorectal cancer expression was surveyed in 10 extended, thoroughly documented HNPCC kindreds. One hundred sixteen patients were found to have 183 colorectal cancers. Despite the striking family history, less than 5% were correctly treated by subtotal colectomy. This provided a unique opportunity to study the natural history. Five findings differed significantly (p <0.05) from patients with sporadic colon cancer: (1) mean age of initial colon cancer diagnosed was 45.6 years; (2) 69.1% of first colon cancers were located proximal to the splenic flexure of the colon; (3) 18.1% had synchronous colon cancer; (4) 24.2% had metachronous colon cancer develop with life table analysis showing the risk for a metachronous lesion at 10 years to be 40%; and (5) only 23.3% of cancers were located in the sigmoid colon or rectum. Based on this data, it is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of this syndrome. If an autosomal dominant inheritance pattern emerges, an in-depth genetic investigation is indicated. When HNPCC is confirmed, the following recommendations apply: a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions. The rectum should be spared in favor of careful lifetime surveillance because of the proclivity for proximal colon cancer involvement. As yet unaffected members of a newly diagnosed HNPCC kindred who are in the 'direct genetic line' should be cautioned that they are at 50% risk and must begin an intensive surveillance program beginning in the third decade with careful attention to the right colon. Patients from newly diagnosed HNPCC families who have had a previous conventional colectomy for colon cancer should, at the very least, enter an intensive surveillance program; a prophylactic completion subtotal colectomy should be considered for patients who are less than totally compliant.

Original languageEnglish
Pages (from-to)289-295
Number of pages7
JournalAnnals of Surgery
Volume206
Issue number3
StatePublished - 1987

Fingerprint

Lynch Syndrome II
Hereditary Nonpolyposis Colorectal Neoplasms
Colonic Neoplasms
Colectomy
Therapeutics
Rectum
Colorectal Neoplasms
Colon
Inheritance Patterns
Transverse Colon
Life Tables
Sigmoid Colon
Polyps
Natural History
Genetic Markers

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). / Fitzgibbons, Robert Joseph; Lynch, Henry T.; Stanislav, G. V.; Watson, P. A.; Lanspa, Stephen J.; Marcus, J. N.; Smyrk, T.; Kriegler, M. D.; Lynch, J. F.

In: Annals of Surgery, Vol. 206, No. 3, 1987, p. 289-295.

Research output: Contribution to journalArticle

Fitzgibbons, RJ, Lynch, HT, Stanislav, GV, Watson, PA, Lanspa, SJ, Marcus, JN, Smyrk, T, Kriegler, MD & Lynch, JF 1987, 'Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)', Annals of Surgery, vol. 206, no. 3, pp. 289-295.
Fitzgibbons, Robert Joseph ; Lynch, Henry T. ; Stanislav, G. V. ; Watson, P. A. ; Lanspa, Stephen J. ; Marcus, J. N. ; Smyrk, T. ; Kriegler, M. D. ; Lynch, J. F. / Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II). In: Annals of Surgery. 1987 ; Vol. 206, No. 3. pp. 289-295.
@article{dfce6e45bda24617a68d2298cbfc1389,
title = "Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)",
abstract = "Primary genetic factors are etiologic in at least 5-10{\%} of patients with colon cancer. The polyposis syndromes (FPC) are easily identified examples because of the spectacular number of polyps. The hereditary nonpolyposis syndromes (HNPCC), although five times more common than FPC, are usually not recognized because they do not have such a distinctive clinical, premonitory genetic marker. Colorectal cancer expression was surveyed in 10 extended, thoroughly documented HNPCC kindreds. One hundred sixteen patients were found to have 183 colorectal cancers. Despite the striking family history, less than 5{\%} were correctly treated by subtotal colectomy. This provided a unique opportunity to study the natural history. Five findings differed significantly (p <0.05) from patients with sporadic colon cancer: (1) mean age of initial colon cancer diagnosed was 45.6 years; (2) 69.1{\%} of first colon cancers were located proximal to the splenic flexure of the colon; (3) 18.1{\%} had synchronous colon cancer; (4) 24.2{\%} had metachronous colon cancer develop with life table analysis showing the risk for a metachronous lesion at 10 years to be 40{\%}; and (5) only 23.3{\%} of cancers were located in the sigmoid colon or rectum. Based on this data, it is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of this syndrome. If an autosomal dominant inheritance pattern emerges, an in-depth genetic investigation is indicated. When HNPCC is confirmed, the following recommendations apply: a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions. The rectum should be spared in favor of careful lifetime surveillance because of the proclivity for proximal colon cancer involvement. As yet unaffected members of a newly diagnosed HNPCC kindred who are in the 'direct genetic line' should be cautioned that they are at 50{\%} risk and must begin an intensive surveillance program beginning in the third decade with careful attention to the right colon. Patients from newly diagnosed HNPCC families who have had a previous conventional colectomy for colon cancer should, at the very least, enter an intensive surveillance program; a prophylactic completion subtotal colectomy should be considered for patients who are less than totally compliant.",
author = "Fitzgibbons, {Robert Joseph} and Lynch, {Henry T.} and Stanislav, {G. V.} and Watson, {P. A.} and Lanspa, {Stephen J.} and Marcus, {J. N.} and T. Smyrk and Kriegler, {M. D.} and Lynch, {J. F.}",
year = "1987",
language = "English",
volume = "206",
pages = "289--295",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Recognition and treatment of patients with hereditary nonpolyposis colon cancer (Lynch syndromes I and II)

AU - Fitzgibbons, Robert Joseph

AU - Lynch, Henry T.

AU - Stanislav, G. V.

AU - Watson, P. A.

AU - Lanspa, Stephen J.

AU - Marcus, J. N.

AU - Smyrk, T.

AU - Kriegler, M. D.

AU - Lynch, J. F.

PY - 1987

Y1 - 1987

N2 - Primary genetic factors are etiologic in at least 5-10% of patients with colon cancer. The polyposis syndromes (FPC) are easily identified examples because of the spectacular number of polyps. The hereditary nonpolyposis syndromes (HNPCC), although five times more common than FPC, are usually not recognized because they do not have such a distinctive clinical, premonitory genetic marker. Colorectal cancer expression was surveyed in 10 extended, thoroughly documented HNPCC kindreds. One hundred sixteen patients were found to have 183 colorectal cancers. Despite the striking family history, less than 5% were correctly treated by subtotal colectomy. This provided a unique opportunity to study the natural history. Five findings differed significantly (p <0.05) from patients with sporadic colon cancer: (1) mean age of initial colon cancer diagnosed was 45.6 years; (2) 69.1% of first colon cancers were located proximal to the splenic flexure of the colon; (3) 18.1% had synchronous colon cancer; (4) 24.2% had metachronous colon cancer develop with life table analysis showing the risk for a metachronous lesion at 10 years to be 40%; and (5) only 23.3% of cancers were located in the sigmoid colon or rectum. Based on this data, it is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of this syndrome. If an autosomal dominant inheritance pattern emerges, an in-depth genetic investigation is indicated. When HNPCC is confirmed, the following recommendations apply: a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions. The rectum should be spared in favor of careful lifetime surveillance because of the proclivity for proximal colon cancer involvement. As yet unaffected members of a newly diagnosed HNPCC kindred who are in the 'direct genetic line' should be cautioned that they are at 50% risk and must begin an intensive surveillance program beginning in the third decade with careful attention to the right colon. Patients from newly diagnosed HNPCC families who have had a previous conventional colectomy for colon cancer should, at the very least, enter an intensive surveillance program; a prophylactic completion subtotal colectomy should be considered for patients who are less than totally compliant.

AB - Primary genetic factors are etiologic in at least 5-10% of patients with colon cancer. The polyposis syndromes (FPC) are easily identified examples because of the spectacular number of polyps. The hereditary nonpolyposis syndromes (HNPCC), although five times more common than FPC, are usually not recognized because they do not have such a distinctive clinical, premonitory genetic marker. Colorectal cancer expression was surveyed in 10 extended, thoroughly documented HNPCC kindreds. One hundred sixteen patients were found to have 183 colorectal cancers. Despite the striking family history, less than 5% were correctly treated by subtotal colectomy. This provided a unique opportunity to study the natural history. Five findings differed significantly (p <0.05) from patients with sporadic colon cancer: (1) mean age of initial colon cancer diagnosed was 45.6 years; (2) 69.1% of first colon cancers were located proximal to the splenic flexure of the colon; (3) 18.1% had synchronous colon cancer; (4) 24.2% had metachronous colon cancer develop with life table analysis showing the risk for a metachronous lesion at 10 years to be 40%; and (5) only 23.3% of cancers were located in the sigmoid colon or rectum. Based on this data, it is recommended that the family history of all patients with a newly diagnosed colon cancer be evaluated for evidence of this syndrome. If an autosomal dominant inheritance pattern emerges, an in-depth genetic investigation is indicated. When HNPCC is confirmed, the following recommendations apply: a subtotal abdominal colectomy is indicated at the time of the initial colon cancer because of the risk of synchronous and metachronous lesions. The rectum should be spared in favor of careful lifetime surveillance because of the proclivity for proximal colon cancer involvement. As yet unaffected members of a newly diagnosed HNPCC kindred who are in the 'direct genetic line' should be cautioned that they are at 50% risk and must begin an intensive surveillance program beginning in the third decade with careful attention to the right colon. Patients from newly diagnosed HNPCC families who have had a previous conventional colectomy for colon cancer should, at the very least, enter an intensive surveillance program; a prophylactic completion subtotal colectomy should be considered for patients who are less than totally compliant.

UR - http://www.scopus.com/inward/record.url?scp=0023204649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023204649&partnerID=8YFLogxK

M3 - Article

VL - 206

SP - 289

EP - 295

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -